Preference and quality of life of adult chronic obstructive lung disease (COPD) patients when using a novel mesh nebulizer compared to traditional jet nebulizer (TJN)

C. Nickerson (Murrysville, United States of America), D. Von Hollen (Murrysville, United States of America), S. Garbin (Murrysville, United States of America), K. Doty (Murrysville, United States of America), J. Jasko (Murrysville, United States of America), C. Cain (Murrysville, United States of America)

Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more
Session: Inhaler devices in COPD: technical advances, adherence studies and more
Session type: E-poster session
Number: 640
Disease area: -

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Nickerson (Murrysville, United States of America), D. Von Hollen (Murrysville, United States of America), S. Garbin (Murrysville, United States of America), K. Doty (Murrysville, United States of America), J. Jasko (Murrysville, United States of America), C. Cain (Murrysville, United States of America). Preference and quality of life of adult chronic obstructive lung disease (COPD) patients when using a novel mesh nebulizer compared to traditional jet nebulizer (TJN). 640

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Exercise capacity and dyspnea challenge of adult chronic obstructive lung disease (COPD) patients when using a novel mesh nebulizer compared to traditional jet nebulizer (TJN)
Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more
Year: 2020


How can time to COPD exacerbation be delayed? A real-world study comparing two oscillating positive expiratory pressure (OPEP) devices in patients with chronic obstructive pulmonary disease (COPD) or chronic bronchitis
Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more
Year: 2020


A bench study to investigate the effect of heated humidification on patient-ventilator asynchrony (PVA) in patients with chronic obstructive pulmonary disease (COPD) during non-invasive ventilation (NIV)
Source: Annual Congress 2013 –Long-term NIV: COPD, sleep, obesity and outcomes
Year: 2013


Medical personnel‘s ability to use pressurized metered dose inhaler (pMDI) in India
Source: Annual Congress 2006 - The challenges of managing asthma in primary care
Year: 2006


Monitorization of β2-adrenergic effects in carriers of chronic obstructive pulmonary disease (COPD) using ultra-sonic and jet nebulization
Source: Eur Respir J 2002; 20: Suppl. 38, 182s
Year: 2002

The use of the cyclical sigh function in long term non-invasive ventilation (NIV) as a method of lung volume recruitment to control hypercapnia in a patient with severe chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – Noninvasive ventilation and beyond: novelties and real-life applications
Year: 2016


The influence of inhalation device for bronchodilators on the results of therapy in primary care patients with bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Asthma control or asthma severity
Year: 2008


Indacaterol/glycopyrronium (IND/GLY) is cost-effective compared with salmeterol/fluticasone (SFC) in Swedish chronic obstructive pulmonary disease (COPD) patients
Source: International Congress 2017 – Primary care diagnosis, assessment and management of COPD
Year: 2017

Home non-invasive ventilation (NIV) adherence for chronic respiratory failure treatment of obesity hypoventilation syndrome (OHS) vs. chronic obstructive lung disease (COPD)
Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects
Year: 2019

A 6 week study of the efficacy and safety of UK-500,001 dry powder for inhalation (DPI) in adults with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2007 - New insights into the treatment of COPD
Year: 2007


A pilot study to assess the efficacy of breathlessness plans for patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016

Comparison of inspiratory flow rates using an innovative dry powder inhaler (DPI) in patients with mild–severe asthma and severe COPD
Source: International Congress 2014 – Rationale behind respiratory drug development
Year: 2014

Quality of life in home ventilation (QUALIHOV)
Source: Annual Congress 2006 - Interventions and outcome in chronic respiratory failure - new aspects and deeper insights
Year: 2006


Aerosolotherapy in stable chronic obstructive pulmonary disease (COPD) – common inhalers use ability and usefulness of PIF measurement in choice of inhalers
Source: Annual Congress 2007 - Managing COPD in primary care
Year: 2007


Monitoring of the β2-adrenergic effects in chronic obstructive pulmonary disease patients using an ultrasonic and a jet nebulizer
Source: Eur Respir J 2001; 18: Suppl. 33, 136s
Year: 2001

Lung deposition of two bronchodilators in subjects with (COPD) when administered via standard jet nebulizer or Handihaler® using functional respiratory imaging (FRI).
Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more
Year: 2020


Pulmonary function response in smokers and patients with chronic obstructive lung disease (COPD) following exposure to concentrated fine (PM2.5) particles
Source: Annual Congress 2009 - Indoor and outdoor air pollution
Year: 2009


Inhalation characteristics of asthmatic children (child), adults asthmatics (adult) and chronic obstructive pulmonary disease patients when they inhale through a spiromax dry powder inhaler (DPI)
Source: Annual Congress 2009 - New aspects of inhalation therapy
Year: 2009


Quality of life in patients with chronic obstructive pulmonary disease (COPD) and long-term oxygen therapy (LTOT)
Source: Eur Respir J 2001; 18: Suppl. 33, 486s
Year: 2001

Home non-invasive ventilation (NIV) for chronic obstructive pulmonary disease (COPD) after hypercapnic exacerbation: does local practice reflect evidence?
Source: International Congress 2019 – Hot topics in noninvasive ventilation
Year: 2019